Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 38% ± 13% | |
brain | 14 studies | 34% ± 15% | |
intestine | 8 studies | 39% ± 26% | |
peripheral blood | 6 studies | 49% ± 19% | |
liver | 6 studies | 32% ± 8% | |
kidney | 5 studies | 36% ± 15% | |
eye | 5 studies | 38% ± 19% | |
uterus | 5 studies | 59% ± 32% | |
pancreas | 4 studies | 50% ± 27% | |
adipose | 4 studies | 29% ± 12% | |
breast | 4 studies | 47% ± 21% | |
prostate | 4 studies | 35% ± 9% | |
heart | 3 studies | 28% ± 14% | |
lymph node | 3 studies | 42% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 36410.36 | 180 / 180 | 100% | 299.61 | 430 / 430 |
skin | 100% | 31493.97 | 1808 / 1809 | 100% | 427.17 | 472 / 472 |
thymus | 100% | 36166.13 | 653 / 653 | 100% | 267.57 | 604 / 605 |
kidney | 100% | 34675.74 | 89 / 89 | 100% | 273.76 | 898 / 901 |
prostate | 100% | 40662.26 | 245 / 245 | 100% | 307.66 | 500 / 502 |
brain | 100% | 22624.75 | 2629 / 2642 | 100% | 422.70 | 705 / 705 |
lung | 100% | 45458.73 | 578 / 578 | 99% | 198.94 | 1143 / 1155 |
breast | 100% | 46031.41 | 459 / 459 | 99% | 244.28 | 1106 / 1118 |
bladder | 100% | 43965.52 | 21 / 21 | 98% | 195.19 | 496 / 504 |
stomach | 99% | 24508.89 | 356 / 359 | 98% | 160.30 | 281 / 286 |
intestine | 100% | 41419.98 | 963 / 966 | 97% | 176.19 | 513 / 527 |
uterus | 100% | 73912.92 | 170 / 170 | 97% | 193.48 | 445 / 459 |
pancreas | 98% | 14580.31 | 322 / 328 | 98% | 210.37 | 175 / 178 |
liver | 100% | 36096.42 | 226 / 226 | 95% | 181.24 | 385 / 406 |
adrenal gland | 99% | 16979.00 | 256 / 258 | 93% | 207.25 | 213 / 230 |
esophagus | 100% | 36931.52 | 1443 / 1445 | 91% | 98.16 | 167 / 183 |
adipose | 100% | 51400.91 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 46604.08 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 585.04 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 346.49 | 29 / 29 |
spleen | 100% | 37526.05 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 136.19 | 1 / 1 |
heart | 99% | 33186.47 | 856 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 133.48 | 43 / 45 |
muscle | 55% | 4979.55 | 445 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 34% | 4033.91 | 319 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2001190 | Biological process | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO_0050862 | Biological process | positive regulation of T cell receptor signaling pathway |
GO_0031623 | Biological process | receptor internalization |
GO_0014905 | Biological process | myoblast fusion involved in skeletal muscle regeneration |
GO_0001771 | Biological process | immunological synapse formation |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0002863 | Biological process | positive regulation of inflammatory response to antigenic stimulus |
GO_0034238 | Biological process | macrophage fusion |
GO_0050861 | Biological process | positive regulation of B cell receptor signaling pathway |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0072675 | Biological process | osteoclast fusion |
GO_2000553 | Biological process | positive regulation of T-helper 2 cell cytokine production |
GO_0070863 | Biological process | positive regulation of protein exit from endoplasmic reticulum |
GO_0035783 | Biological process | CD4-positive, alpha-beta T cell costimulation |
GO_0046718 | Biological process | symbiont entry into host cell |
GO_0071404 | Biological process | cellular response to low-density lipoprotein particle stimulus |
GO_1903911 | Biological process | positive regulation of receptor clustering |
GO_0061462 | Biological process | protein localization to lysosome |
GO_0030890 | Biological process | positive regulation of B cell proliferation |
GO_2000563 | Biological process | positive regulation of CD4-positive, alpha-beta T cell proliferation |
GO_1905676 | Biological process | positive regulation of adaptive immune memory response |
GO_1905521 | Biological process | regulation of macrophage migration |
GO_1904352 | Biological process | positive regulation of protein catabolic process in the vacuole |
GO_0002455 | Biological process | humoral immune response mediated by circulating immunoglobulin |
GO_0031647 | Biological process | regulation of protein stability |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0001772 | Cellular component | immunological synapse |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0009925 | Cellular component | basal plasma membrane |
GO_0005925 | Cellular component | focal adhesion |
GO_0097197 | Cellular component | tetraspanin-enriched microdomain |
GO_0031982 | Cellular component | vesicle |
GO_1990459 | Molecular function | transferrin receptor binding |
GO_0015485 | Molecular function | cholesterol binding |
GO_0042289 | Molecular function | MHC class II protein binding |
GO_0001618 | Molecular function | virus receptor activity |
GO_0005178 | Molecular function | integrin binding |
GO_0023026 | Molecular function | MHC class II protein complex binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CD81 |
Protein name | CD81 molecule Tetraspanin CD81 antigen (26 kDa cell surface protein TAPA-1) (Target of the antiproliferative antibody 1) (Tetraspanin-28) (Tspan-28) (CD antigen CD81) |
Synonyms | TSPAN28 TAPA1 |
Description | FUNCTION: Structural component of specialized membrane microdomains known as tetraspanin-enriched microdomains (TERMs), which act as platforms for receptor clustering and signaling. Essential for trafficking and compartmentalization of CD19 receptor on the surface of activated B cells . Upon initial encounter with microbial pathogens, enables the assembly of CD19-CR2/CD21 and B cell receptor (BCR) complexes at signaling TERMs, lowering the threshold dose of antigen required to trigger B cell clonal expansion and antibody production . In T cells, facilitates the localization of CD247/CD3 zeta at antigen-induced synapses with B cells, providing for costimulation and polarization toward T helper type 2 phenotype . Present in MHC class II compartments, may also play a role in antigen presentation . Can act both as positive and negative regulator of homotypic or heterotypic cell-cell fusion processes. Positively regulates sperm-egg fusion and may be involved in acrosome reaction (By similarity). In myoblasts, associates with CD9 and PTGFRN and inhibits myotube fusion during muscle regeneration (By similarity). In macrophages, associates with CD9 and beta-1 and beta-2 integrins, and prevents macrophage fusion into multinucleated giant cells specialized in ingesting complement-opsonized large particles . Also prevents the fusion of mononuclear cell progenitors into osteoclasts in charge of bone resorption (By similarity). May regulate the compartmentalization of enzymatic activities. In T cells, defines the subcellular localization of dNTPase SAMHD1 and permits its degradation by the proteasome, thereby controlling intracellular dNTP levels . Also involved in cell adhesion and motility. Positively regulates integrin-mediated adhesion of macrophages, particularly relevant for the inflammatory response in the lung (By similarity). .; FUNCTION: (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes. Association with CLDN1 and the CLDN1-CD81 receptor complex is essential for HCV entry into host cell. .; FUNCTION: (Microbial infection) Involved in SAMHD1-dependent restriction of HIV-1 replication. May support early replication of both R5- and X4-tropic HIV-1 viruses in T cells, likely via proteasome-dependent degradation of SAMHD1. .; FUNCTION: (Microbial infection) Specifically required for Plasmodium falciparum infectivity of hepatocytes, controlling sporozoite entry into hepatocytes via the parasitophorous vacuole and subsequent parasite differentiation to exoerythrocytic forms. . |
Accessions | ENST00000475945.7 ENST00000527343.5 ENST00000493525.6 ENST00000530648.5 ENST00000481687.1 ENST00000464784.6 E9PJK1 H0YDL9 H0YEE2 P60033 ENST00000381036.7 ENST00000533417.6 ENST00000492627.5 A6NMH8 ENST00000263645.10 ENST00000526072.5 E9PQV4 E9PPF5 ENST00000492252.5 E9PIF1 E9PRJ8 H0YDJ9 |